Baxdela (Melinta Therapeutics). Baxdela is an anionic fluoroquinolone antibiotic. The drug demonstrates in vitro and clinical activity against gram-positive and gram-negative pathogens, including methicillin-resistant Staphylococcus aureus.
 |
RETURN TO FULL LIST |  |
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.